Boxer Capital as of Sept. 30, 2018
Portfolio Holdings for Boxer Capital
Boxer Capital holds 24 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Solid Biosciences | 15.1 | $136M | 2.9M | 47.18 | |
| Beigene (ONC) | 12.0 | $109M | 630k | 172.22 | |
| Ptc Therapeutics I (PTCT) | 11.2 | $101M | 2.2M | 47.00 | |
| Wave Life Sciences (WVE) | 8.8 | $80M | 1.6M | 50.00 | |
| Mirati Therapeutics | 8.2 | $74M | 1.6M | 47.10 | |
| Esperion Therapeutics (ESPR) | 6.8 | $61M | 1.4M | 44.37 | |
| Odonate Therapeutics Ord | 6.1 | $55M | 2.8M | 19.41 | |
| Rocket Pharmaceuticals (RCKT) | 5.4 | $48M | 2.0M | 24.62 | |
| Medicines Company | 4.7 | $42M | 1.4M | 29.91 | |
| Dbv Technologies S A | 3.7 | $34M | 1.5M | 22.46 | |
| Reata Pharmaceuticals Inc Cl A | 3.6 | $33M | 400k | 81.76 | |
| Kiniksa Pharmaceuticals | 3.3 | $30M | 1.2M | 25.50 | |
| Cymabay Therapeutics | 2.6 | $23M | 2.1M | 11.08 | |
| Amarin Corporation | 2.4 | $21M | 1.3M | 16.27 | |
| Kura Oncology (KURA) | 1.6 | $15M | 845k | 17.50 | |
| Mei Pharma | 1.4 | $13M | 2.9M | 4.31 | |
| Rigel Pharmaceuticals | 0.8 | $7.5M | 2.3M | 3.21 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $4.4M | 200k | 22.11 | |
| Sunesis Pharmaceuticals Inc Ne | 0.5 | $4.3M | 2.1M | 2.00 | |
| Regulus Therapeutics | 0.5 | $4.0M | 1.7M | 2.37 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $4.0M | 300k | 13.20 | |
| Bellerophon Therapeutics | 0.2 | $1.6M | 1.5M | 1.08 | |
| Novus Therapeutics | 0.2 | $1.5M | 324k | 4.67 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $808k | 100k | 8.08 |
